shark liver oil / yeast extract, yeast extract (excluding saccharomyces boulardii)
As the list published 23 Sept 2026 has it, binding since 17 Jun 2026. Each entry binds six months after its own publication date (Article 107c(7) of Directive 2001/83/EC).
What the list says
- EU reference date
- 1 Jan 1957
- PSUR frequency
- 15 years
- Data lock point
- 31 Dec 2031
- Submission date
- 30 Mar 2032
- Next data lock point
- Not stated
- Next submission date
- Not stated
- Products covered
- Nationally authorised (NAP)
Are PSURs required for products referred to in Articles 10(1), 10a and 16a of Directive 2001/83/EC?
No — the list does not require PSURs for these products.
The list asks this as one question for Articles 10(1), 10a and 16a together, and does not answer it for Article 14 at all. A PSUR may in any case be required at the request of a competent authority or as a condition of the marketing authorisation.
Notes in the list
Active substance name was amended on 17/12/2025 New entry added on 21/07/2017
Track dates like these for your own products: a sample workspace, read-only, no account needed.
Try the demoThe next three reports
- Data lock point 31 Dec 2031Submission by 30 Mar 2032
- Data lock point 31 Dec 2046Submission by 31 Mar 2047
- Data lock point 31 Dec 2061Submission by 31 Mar 2062
Counted from the data lock point the list gives, on the cycle it states: the submission date is 90 days after the data lock point — 70 days for a cycle of twelve months or less, 90 days for a longer one, as GVP Module VII sets out.
In earlier versions of the list
EMA/630645/2012 Rev.164 · published 23 Sept 2026
shark liver oil / yeast extract, yeast extract (excluding saccharomyces boulardii) — every 15 years, data lock point 31 Dec 2031
EMA/630645/2012 Rev.156 · published 4 Feb 2026
shark liver oil / yeast extract, yeast extract (excluding saccharomyces boulardii) — every 15 years, data lock point 31 Dec 2031
Source: European Medicines Agency, list of EU reference dates and frequency of submission of periodic safety update reports, EMA/630645/2012 Rev.164, published 23 Sept 2026. Open the published file
Kreastel is a planning and oversight aid for pharmacovigilance obligations. It tracks dates like these for a marketing authorisation holder's own products.
Report a discrepancy — if this page and the published file disagree, the file is right and we want to know.